Veon (VEON) Cash & Equivalents (2009 - 2026)

Veon has reported Cash & Equivalents for 18 years, with the latest figure at $2.2 billion in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $2.2 billion, up 71.06% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.2 billion (up 71.06% YoY), and the FY2025 annual result was $1.7 billion, up 2.55% from the prior year.
• Cash & Equivalents improved to $2.2 billion in Q2 2026, from $1.7 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.5 billion in Q2 2023 and troughed at $2.0 million in Q3 2024.
• A 5-year average of $1.3 billion and a median of $1.5 billion in 2024 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2022, when Cash & Equivalents slumped 88.89%; it then surged 42125.0% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $6.0 million in 2022, then slumped by 33.33% to $4.0 million in 2023, then surged by 42125.0% to $1.7 billion in 2024, then advanced by 2.55% to $1.7 billion in 2025, then grew by 26.62% to $2.2 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $2.2 billion in Q2 2026, $1.7 billion in Q4 2025, and $1.3 billion in Q2 2025.